USFDA completes inspection at Dishman Carbogen’s Naroda facility

15 Feb 2019 Evaluate

The US Food and Drug Administration (USFDA) has successfully completed the inspection at Dishman Carbogen Amcis’ Naroda facility in Ahmedabad on February 15, 2019. The inspection was concluded without any observations or Form 483's.

Thus, the Company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the USFDA.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

160.35 1.80 (1.14%)
10-Mar-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.70
Dr. Reddys Lab 1315.10
Cipla 1321.95
Zydus Lifesciences 917.10
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×